chr1-10295776-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001365951.3(KIF1B):​c.1777+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.29 in 1,603,204 control chromosomes in the GnomAD database, including 68,451 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5595 hom., cov: 31)
Exomes 𝑓: 0.29 ( 62856 hom. )

Consequence

KIF1B
NM_001365951.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.262
Variant links:
Genes affected
KIF1B (HGNC:16636): (kinesin family member 1B) Predicted to enable microtubule binding activity and plus-end-directed microtubule motor activity. Predicted to be involved in chemical synaptic transmission; dense core granule cytoskeletal transport; and vesicle-mediated transport. Predicted to act upstream of or within mitochondrion transport along microtubule. Predicted to be located in cytoplasmic vesicle membrane and neuron projection. Predicted to be part of kinesin complex. Predicted to be active in several cellular components, including axon; dendrite; and microtubule. Implicated in Charcot-Marie-Tooth disease type 2A1; carcinoma (multiple); multiple sclerosis; neuroblastoma; and pheochromocytoma. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-10295776-C-T is Benign according to our data. Variant chr1-10295776-C-T is described in ClinVar as [Benign]. Clinvar id is 177960.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-10295776-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.317 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KIF1BNM_001365951.3 linkuse as main transcriptc.1777+10C>T intron_variant ENST00000676179.1 NP_001352880.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KIF1BENST00000676179.1 linkuse as main transcriptc.1777+10C>T intron_variant NM_001365951.3 ENSP00000502065.1 O60333-1

Frequencies

GnomAD3 genomes
AF:
0.266
AC:
40398
AN:
151908
Hom.:
5574
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.190
Gnomad AMI
AF:
0.365
Gnomad AMR
AF:
0.323
Gnomad ASJ
AF:
0.271
Gnomad EAS
AF:
0.284
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.292
Gnomad MID
AF:
0.242
Gnomad NFE
AF:
0.294
Gnomad OTH
AF:
0.272
GnomAD3 exomes
AF:
0.284
AC:
71355
AN:
250910
Hom.:
10438
AF XY:
0.281
AC XY:
38082
AN XY:
135620
show subpopulations
Gnomad AFR exome
AF:
0.187
Gnomad AMR exome
AF:
0.350
Gnomad ASJ exome
AF:
0.275
Gnomad EAS exome
AF:
0.291
Gnomad SAS exome
AF:
0.230
Gnomad FIN exome
AF:
0.293
Gnomad NFE exome
AF:
0.292
Gnomad OTH exome
AF:
0.269
GnomAD4 exome
AF:
0.293
AC:
424561
AN:
1451178
Hom.:
62856
Cov.:
27
AF XY:
0.291
AC XY:
210002
AN XY:
722420
show subpopulations
Gnomad4 AFR exome
AF:
0.182
Gnomad4 AMR exome
AF:
0.343
Gnomad4 ASJ exome
AF:
0.276
Gnomad4 EAS exome
AF:
0.257
Gnomad4 SAS exome
AF:
0.226
Gnomad4 FIN exome
AF:
0.301
Gnomad4 NFE exome
AF:
0.301
Gnomad4 OTH exome
AF:
0.289
GnomAD4 genome
AF:
0.266
AC:
40461
AN:
152026
Hom.:
5595
Cov.:
31
AF XY:
0.267
AC XY:
19805
AN XY:
74294
show subpopulations
Gnomad4 AFR
AF:
0.190
Gnomad4 AMR
AF:
0.324
Gnomad4 ASJ
AF:
0.271
Gnomad4 EAS
AF:
0.284
Gnomad4 SAS
AF:
0.239
Gnomad4 FIN
AF:
0.292
Gnomad4 NFE
AF:
0.294
Gnomad4 OTH
AF:
0.277
Alfa
AF:
0.276
Hom.:
1344
Bravo
AF:
0.267
Asia WGS
AF:
0.278
AC:
963
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 28, 2020This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 20, 2013The 1639+10C_T variant in KIF1B: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, has been identified in 30% (2553/8600) of Euro pean American chromosomes and 26% (820/4406) of African American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs3 753037). -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Pheochromocytoma Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 19, 2021- -
Neuroblastoma Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Charcot-Marie-Tooth disease type 2 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Charcot-Marie-Tooth disease type 2A1 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 19, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.3
DANN
Benign
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3753037; hg19: chr1-10355834; COSMIC: COSV55805392; COSMIC: COSV55805392; API